283 related articles for article (PubMed ID: 24466060)
1. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture.
Gieseck RL; Hannan NR; Bort R; Hanley NA; Drake RA; Cameron GW; Wynn TA; Vallier L
PLoS One; 2014; 9(1):e86372. PubMed ID: 24466060
[TBL] [Abstract][Full Text] [Related]
2. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
[TBL] [Abstract][Full Text] [Related]
3. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
Gao X; Liu Y
Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes.
Qosa H; Ribeiro AJS; Hartman NR; Volpe DA
J Pharmacol Toxicol Methods; 2021; 110():107083. PubMed ID: 34098110
[TBL] [Abstract][Full Text] [Related]
5. Efficient hepatic differentiation of human induced pluripotent stem cells in a three-dimensional microscale culture.
Zhang RR; Takebe T; Miyazaki L; Takayama M; Koike H; Kimura M; Enomura M; Zheng YW; Sekine K; Taniguchi H
Methods Mol Biol; 2014; 1210():131-41. PubMed ID: 25173165
[TBL] [Abstract][Full Text] [Related]
6. Human-Induced Pluripotent Stem Cell-Derived Hepatocytes and their Culturing Methods to Maintain Liver Functions for Pharmacokinetics and Safety Evaluation of Pharmaceuticals.
Inoue T; Iwazaki N; Araki T; Hitotsumachi H
Curr Pharm Biotechnol; 2020; 21(9):773-779. PubMed ID: 32003687
[TBL] [Abstract][Full Text] [Related]
7. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.
Ma X; Qu X; Zhu W; Li YS; Yuan S; Zhang H; Liu J; Wang P; Lai CS; Zanella F; Feng GS; Sheikh F; Chien S; Chen S
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2206-11. PubMed ID: 26858399
[TBL] [Abstract][Full Text] [Related]
8. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
[TBL] [Abstract][Full Text] [Related]
9. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes.
Ardalani H; Sengupta S; Harms V; Vickerman V; Thomson JA; Murphy WL
Acta Biomater; 2019 Sep; 95():371-381. PubMed ID: 31362140
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.
Chiang CH; Wu WW; Li HY; Chien Y; Sun CC; Peng CH; Lin AT; Huang CS; Lai YH; Chiou SH; Hung SI; Chang YL; Lan YT; Liu DM; Chien CS; Huo TI; Lee SD; Wang CY
Cell Transplant; 2015; 24(3):541-59. PubMed ID: 25668102
[TBL] [Abstract][Full Text] [Related]
11. Human Induced Pluripotent Stem Cell-Derived Definitive Endoderm Bulk Culture and Hepatic Differentiation.
Palakkan AA; Nanda J; Ross JA
Methods Mol Biol; 2019; 1994():41-53. PubMed ID: 31124103
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
13. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
14. iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery.
Gurevich I; Burton SA; Munn C; Ohshima M; Goedland ME; Czysz K; Rajesh D
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33268331
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
Chien Y; Chang YL; Li HY; Larsson M; Wu WW; Chien CS; Wang CY; Chu PY; Chen KH; Lo WL; Chiou SH; Lan YT; Huo TI; Lee SD; Huang PI
Acta Biomater; 2015 Feb; 13():228-44. PubMed ID: 25463491
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases.
Holmgren G; Ulfenborg B; Asplund A; Toet K; Andersson CX; Hammarstedt A; Hanemaaijer R; Küppers-Munther B; Synnergren J
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940797
[TBL] [Abstract][Full Text] [Related]
17. Decellularized Liver Extracellular Matrix as Promising Tools for Transplantable Bioengineered Liver Promotes Hepatic Lineage Commitments of Induced Pluripotent Stem Cells.
Park KM; Hussein KH; Hong SH; Ahn C; Yang SR; Park SM; Kweon OK; Kim BM; Woo HM
Tissue Eng Part A; 2016 Mar; 22(5-6):449-60. PubMed ID: 26801816
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype by Three-Dimensional Hydrogel Models.
Toivonen S; Malinen MM; Küblbeck J; Petsalo A; Urtti A; Honkakoski P; Otonkoski T
Tissue Eng Part A; 2016 Jul; 22(13-14):971-84. PubMed ID: 27329070
[TBL] [Abstract][Full Text] [Related]
19. Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes.
Zabulica M; Srinivasan RC; Vosough M; Hammarstedt C; Wu T; Gramignoli R; Ellis E; Kannisto K; Collin de l'Hortet A; Takeishi K; Soto-Gutierrez A; Strom SC
Stem Cells Dev; 2019 Jul; 28(14):907-919. PubMed ID: 31122128
[TBL] [Abstract][Full Text] [Related]
20. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG
Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
